Raymond G. Goodwin

18.2k total citations · 9 hit papers
52 papers, 14.8k citations indexed

About

Raymond G. Goodwin is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Raymond G. Goodwin has authored 52 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 20 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Raymond G. Goodwin's work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (14 papers). Raymond G. Goodwin is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (14 papers). Raymond G. Goodwin collaborates with scholars based in United States, Canada and Australia. Raymond G. Goodwin's co-authors include Craig A. Smith, Terry Farrah, Pamela J. Smolak, Charles T. Rauch, Ken Schooley, Wenie S. Din, David H. Lynch, David Cosman, Steven R. Wiley and Terri Smith and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Raymond G. Goodwin

52 papers receiving 14.4k citations

Hit Papers

Identification and characterization of a new member of th... 1988 2026 2000 2013 1995 1999 1994 1990 1995 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond G. Goodwin United States 37 8.2k 8.0k 3.1k 2.9k 1.8k 52 14.8k
Shin Yonehara Japan 66 9.0k 1.1× 10.3k 1.3× 3.3k 1.1× 1.7k 0.6× 1.9k 1.1× 172 18.7k
Charles T. Rauch United States 24 5.3k 0.6× 8.2k 1.0× 3.2k 1.0× 2.6k 0.9× 1.3k 0.8× 33 14.1k
Kazuo Sugamura Japan 78 12.2k 1.5× 4.9k 0.6× 4.0k 1.3× 1.5k 0.5× 1.4k 0.8× 304 20.8k
Nobuhiko Kayagaki Japan 57 9.2k 1.1× 11.5k 1.4× 1.9k 0.6× 2.1k 0.7× 2.0k 1.1× 98 17.4k
Salem Chouaı̈b France 69 8.9k 1.1× 6.0k 0.7× 6.3k 2.0× 3.9k 1.4× 1.6k 0.9× 328 17.2k
Chikao Morimoto United States 74 8.4k 1.0× 5.1k 0.6× 5.6k 1.8× 1.7k 0.6× 1.4k 0.8× 339 18.5k
Michael J. Grusby United States 77 14.1k 1.7× 4.7k 0.6× 4.3k 1.4× 1.3k 0.4× 2.1k 1.2× 140 20.9k
Naoko Arai Japan 53 6.0k 0.7× 5.3k 0.7× 2.2k 0.7× 894 0.3× 896 0.5× 125 12.3k
Ivan D. Horak United States 62 5.7k 0.7× 4.8k 0.6× 3.9k 1.2× 1.1k 0.4× 1.1k 0.6× 205 14.0k
David M. Tarlinton Australia 68 12.3k 1.5× 4.8k 0.6× 2.5k 0.8× 1.4k 0.5× 1.1k 0.6× 183 17.0k

Countries citing papers authored by Raymond G. Goodwin

Since Specialization
Citations

This map shows the geographic impact of Raymond G. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond G. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond G. Goodwin more than expected).

Fields of papers citing papers by Raymond G. Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond G. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond G. Goodwin. The network helps show where Raymond G. Goodwin may publish in the future.

Co-authorship network of co-authors of Raymond G. Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond G. Goodwin. A scholar is included among the top collaborators of Raymond G. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond G. Goodwin. Raymond G. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clodi, Katharina, Yang Li, Raymond G. Goodwin, et al.. (2000). Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells. British Journal of Haematology. 111(2). 580–586. 64 indexed citations
2.
Walczak, Henning, Robert E. Miller, K. Ariail, et al.. (1999). Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo. Nature Medicine. 5(2). 157–163. 2158 indexed citations breakdown →
3.
Cerutti, Andrea, András Schaffer, Shefali Shah, et al.. (1998). CD30 Is a CD40-Inducible Molecule that Negatively Regulates CD40-Mediated Immunoglobulin Class Switching in Non-Antigen-Selected Human B Cells. Immunity. 9(2). 247–256. 62 indexed citations
4.
Snell, Virginia, Katharina Clodi, Shourong Zhao, et al.. (1997). Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies. British Journal of Haematology. 99(3). 618–624. 111 indexed citations
5.
Degli‐Esposti, Mariapia A., et al.. (1997). The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain. Immunity. 7(6). 813–820. 722 indexed citations breakdown →
6.
Degli‐Esposti, Mariapia A., Pamela J. Smolak, Henning Walczak, et al.. (1997). Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family. The Journal of Experimental Medicine. 186(7). 1165–1170. 543 indexed citations breakdown →
7.
Gruss, H J, Antonio Pinto, Annunziata Gloghini, et al.. (1996). CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.. PubMed. 149(2). 469–81. 67 indexed citations
8.
Smith, Craig A., et al.. (1996). Cowpox Virus Genome Encodes a Second Soluble Homologue of Cellular TNF Receptors, Distinct from CrmB, That Binds TNF but Not LTα. Virology. 223(1). 132–147. 104 indexed citations
9.
Wiley, Steven R., Raymond G. Goodwin, & Colin Smith. (1996). Reverse signaling via CD30 ligand. The Journal of Immunology. 157(8). 3635–3639. 155 indexed citations
10.
Alderson, Mark R., Teresa W. Tough, Terri Davis‐Smith, et al.. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes.. The Journal of Experimental Medicine. 181(1). 71–77. 812 indexed citations breakdown →
11.
Wiley, Steven R., Ken Schooley, Pamela J. Smolak, et al.. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3(6). 673–682. 2479 indexed citations breakdown →
12.
Lynch, David H., Mark L. Watson, Mark R. Alderson, et al.. (1994). The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1(2). 131–136. 290 indexed citations
13.
Gruss, H J, et al.. (1994). Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.. PubMed. 8(12). 2083–94. 53 indexed citations
14.
Smith, Craig A., Terry Farrah, & Raymond G. Goodwin. (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell. 76(6). 959–962. 1640 indexed citations breakdown →
15.
Goodwin, Raymond G., Wenie S. Din, Terri Davis‐Smith, et al.. (1993). Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. European Journal of Immunology. 23(10). 2631–2641. 280 indexed citations
16.
Overell, Robert W., David H. Lynch, R Jerzy, et al.. (1991). Interleukin-7 Retroviruses Transform Pre-B Cells by an Autocrine Mechanism Not Evident in Abelson Murine Leukemia Virus Transformants. Molecular and Cellular Biology. 11(3). 1590–1597. 3 indexed citations
17.
Smith, Craig A., J Wignall, Wenie S. Din, et al.. (1991). T2 open reading frame from the shope fibroma virus encodes a soluble form of the TNF receptor. Biochemical and Biophysical Research Communications. 176(1). 335–342. 185 indexed citations
18.
Goodwin, Raymond G.. (1990). Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily. Cell. 60(6). 941–951. 521 indexed citations breakdown →
19.
Morrissey, Philip, Raymond G. Goodwin, Richard P. Nordan, et al.. (1989). Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.. The Journal of Experimental Medicine. 169(3). 707–716. 190 indexed citations
20.
Goodwin, Raymond G., et al.. (1986). c-erbB activation in avian leukosis virus-induced erythroblastosis: multiple epidermal growth factor receptor mRNAs are generated by alternative RNA processing.. Molecular and Cellular Biology. 6(9). 3128–3133. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026